19

2025-06


Minhai Bio Unites “Min” Hearts in 2025, Striding Toward the Future: The MINI Marathon Relay Concludes Successfully

On the afternoon of June 6, 2025, the MINI Marathon Relay—themed “Uniting the ‘Min’ Spirit, Striding Toward the Future”—concluded successfully on the plaza in front of Building No. 1 at Minhai Biologics’ International Vaccine Industrial Base. Employees’ enthusiastic spirit and collaborative teamwork highlighted the company’s dynamic, forward‑looking corporate culture. At the opening ceremony, General Manager Nie delivered a speech, underscoring the company’s people‑oriented development philosophy and encouraging staff to relieve stress and strengthen team cohesion through physical activity. Following the start of the race, participating teams quickly found their rhythm. A professional coach led the warm‑up session, ensuring that employees were in peak condition for the competition; the event itself was lively and engaging, with each team showcasing their ingenuity…

30

2025-04


Nie Xiaoqi, Deputy General Manager of Minhai Biotechnology, has been honored as a 2025 Beijing Model Worker!

On April 29, the Beijing Municipal Conference on Commending Model Workers, Advanced Workers, and Exemplary Collectives was solemnly held at the Beijing Convention Center. With approval from the CPC Beijing Municipal Committee and the Beijing Municipal People’s Government, Nie Xiaoqi, Deputy General Manager of Minhai Biotechnology, was awarded the honorary title of “Beijing Model Worker for 2025.” This year’s commendation placed particular emphasis on recognizing knowledge-based, skill‑driven, and innovation‑oriented workers, focusing on the capital’s major strategic priorities and key industries. Thanks to his outstanding contributions in vaccine production and quality management, Mr. Nie emerged as one of the distinguished representatives honored in the pharmaceutical and healthcare sector. For many years, Mr. Nie has been deeply committed to vaccine industrialization and quality assurance, successively holding positions in production management…

14

2025-03


Minhai Biotechnology and the Chongqing Center for Disease Control and Prevention have signed a strategic cooperation agreement to support the development of public health.

On the afternoon of March 11, 2025, Beijing Minhai Biotechnology Co., Ltd. (hereinafter referred to as “Minhai Bio”) and the Chongqing Center for Disease Control and Prevention (hereinafter referred to as “Chongqing CDC”) successfully held a cooperation and exchange meeting at Minhai Bio’s Internationalization Industrial Base for Novel Vaccines. The meeting was attended by senior company executives, including Zhang Huadong, Director of the Chongqing CDC; Ji Hengqing and Wang Qing, Deputy Directors; and Zheng Haifa, General Manager of Minhai Bio, along with Liu Jiankai, Executive Deputy General Manager and Director of the R&D Center. During the event, Minhai Bio’s heads of R&D and clinical operations presented the company’s development history, its innovative R&D capabilities, and the progress of clinical trials for key projects.

18

2024-11


Minhai Biotechnology was invited to attend the inaugural China Pharmaceutical Valley Future Biologics Innovative Drug Conference.

On November 16, the inaugural China Pharmaceutical Valley Future Biologics Innovative Drug Conference was successfully held at the Kapok Hotel in Daxing District. Hosted by the Management Committee of the Daxing Biopharmaceutical Industry Base of Zhongguancun Science Park and co-organized by six entities—including Beijing Hotgen Biotechnology Co., Ltd. and Beijing Minhai Biotechnology Co., Ltd.—the event brought together numerous academicians, industry experts, and leading entrepreneurs to discuss cutting-edge industry trends, foster deep integration of key factors driving the pharmaceutical and healthcare sectors, and further enhance Daxing District’s influence in the field of innovative drugs. Zheng Haifa, Chief Scientist of Kintor Pharmaceutical and General Manager of Minhai Biotechnology, was invited to attend the conference.

11

2024-05


Liu Xueliang, Deputy Secretary of the Daxing District Party Committee and District Mayor, conducted an in-depth field visit to Minhai Biotechnology, fostering collaborative innovation and inclusive growth.

On May 10, 2024, Liu Xueliang, Deputy Secretary of the CPC Daxing District Committee and District Mayor of Beijing, led a delegation to visit and conduct an on-site inspection of Beijing Minhai Biotechnology Co., Ltd. (hereinafter referred to as Minhai Bio), gaining an in-depth understanding of the development status of key enterprises and industry benchmarks in Daxing District. Joining the visit were Wu Hao, Deputy District Mayor; Zhang Bin, Director of the District Government Office; Tang Shengming, Director of the District Bureau of Statistics; Ma Yanzhu, Director of the District Industrial Promotion Center; and Zhang Liqun, Party Secretary and Chairman of the Biomedical Base, among other leaders. Accompanying the delegation were Liu Jiankai, Executive Deputy General Manager, and Li Guanghui, Deputy General Manager, of Minhai Bio. The delegation, led by Liu Xueliang, conducted field visits and…

< 1...456...31 >